2014

The Zacks Analyst Blog Highlights: BP, Statoil, Total, Chevron and ExxonMobil

CHICAGO, Jan. 29, 2013 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include BP Plc (NYSE: BP), Statoil ASA (NYSE: STO), Total SA (NYSE: TOT), Chevron Corp. (NYSE: CVX) and ExxonMobil Corporation (NYSE: XOM).

(Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Monday's Analyst Blog:

BP Gets Nat Gas Nod in Azerbaijan

BP Plc (NYSE: BP) received an additional 5-year extension (2031 to 2036) from Azerbaijan related to the Shah Deniz gas project. The extension follows the company's deferment of the start date for phase 2 of the project.

The British energy major earlier planned 2018 for the first gas from the second phase of Azerbaijan's Shah Deniz gas project. Now, BP has set the end of 2017for the start-up.

In response to this, Azerbaijan has extended the Shah Deniz production sharing agreement (PSA). BP has been pumping gas in Shah Deniz since the start of its first phase in 2006, with a capacity of 8 billion cubic meters (Bcm). The second phase is estimated to generate an additional 16 Bcm per year.

Shah Deniz stands as Azerbaijan's largest gas field and is estimated to hold 1.2 trillion cubic meters of gas. The offshore Shah Deniz Phase 2 venture is operated by the British oil giant, with the other partners being

Statoil ASA

(NYSE:

STO

),

Total SA

(NYSE:

TOT

), the State Oil Company of Azerbaijan (SOCAR), Lukoil, Turkiye Petrolleri and Naftiran Intertrade.

BP planned to invest $10 billion for the second phase and the project partners expect to transport Azeri gas by a new pipeline to Europe as well as to the existing markets in Georgia and Turkey. In connection with the pipeline stage in Turkey, Vice President SOCAR, Elshad Nassirov, said that the BP-led consortium has already received approval for the construction of the pipeline for phase 2.

Ahead of Turkey, the co-ventures can select the Nabucco-West pipeline into Austria or the rival Trans-Adriatic pipeline (TAP) into Italy. A decision is expected by the middle of this year. The Shah Deniz group is entitled to have a 50% interest in each of the two projects.

Last year, the U.K. major faced hurdles related to the development of the oilfield block Azeri-Chirag-Gunashli (ACG) in the Azerbaijani sector of the Caspian Sea. BP has been sharply criticized by Azerbaijani President Ilham Aliyev for lagging in production from several Caspian Sea oil fields. Lower-than-expected output has cost the Azerbaijan state an estimated US$8.1billion in revenues.

BP is one of the world's largest energy companies, providing customers fuel for transportation, energy for heat and light, retail services and petrochemical products. Although near-term production hiccups remain in Azerbaijan, BP continues to focus on long-term operations and is in discussion with the country for extending the contract and working on the fields after 2024.

ACG oilfields are divided between the operator BP with a 35.8% share and Chevron Corp. (NYSE: CVX), Inpex, SOCAR, Statoil, ExxonMobil Corporation (NYSE: XOM) and others.

BP has a Zacks Rank #3, which is equivalent to a Hold rating for a period of one to three months.

Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leon Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

http://www.zacks.com

 

SOURCE Zacks Investment Research, Inc.



RELATED LINKS
http://www.zacks.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.